World India's Serum Institute seeks approval to make Russia's Sputnik V vaccine On top of the AstraZeneca PLC and Novavax Inc shots it is already producing. Published June 3, 2021 Updated June 3, 2021 12:40pm Save Saved 1 min comment Comments By Reuters Add BRecorder as a trusted source on Google NEW DELHI: The Serum Institute of India has sought regulatory approval to make Russia's Sputnik V COVID-19 vaccine, local media reported on Thursday, on top of the AstraZeneca PLC and Novavax Inc shots it is already producing. AstraZeneca Sputnik V vaccine Comments Comments are closed for this article. More Stories Pakistan launches fixed tax scheme for small retailers Pakistan rejects India's remarks on Gilgit-Baltistan polls, reiterates Kashmir stance Iran says it fired warning missiles and drones at US warships in Gulf of Oman Volatile trading at bourse, KSE-100 sheds nearly 700 points Telenor considering sale of Pakistan’s Easypaisa: report Pakistan risks missing global supply chain shift without pro-export budget measures: PTC Six 'Fitna al Hindustan' terrorists killed in Panjgur IBO: ISPR Oil prices fall after Oman says Mina al Fahal operations proceeding normally Gold price per tola drops Rs1,469 in Pakistan Rupee records gain against US dollar MPA Saqib Chadhar booked under PECA Act for allegedly harassing Momina Iqbal Browse all stories
Comments
Comments are closed for this article.